| Price | 71.00p on 17-12-2025 at 19:35:07 |
|---|---|
| Change | -7.00p -8.86% |
| Buy | 72.00p |
| Sell | 70.00p |
| Last Trade: | Buy 302.00 at 72.00p |
| Day's Volume: | 11,062,103 |
| Last Close: | 72.00p |
| Open: | 82.00p |
| ISIN: | GB00BYYW9G87 |
| Day's Range | 72.00p - 75.00p |
| 52wk Range: | 27.25p - 83.20p |
| Market Capitalisation: | £312.24m |
| VWAP: | 71.44563p |
| Shares in Issue: | 433.66m |
Sector: Medicine and Biotech
Listed In: FTSE AIM All-Share,
Avacta Group (AVCT) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Buy* | 302 | 72.00p | Suspected BUY Trade |
16:35:12 - 17-Dec-25 |
| Unknown* | 50,000 | 71.00p | Ordinary |
16:30:27 - 17-Dec-25 |
| Unknown* | 50,000 | 71.00p | Ordinary |
16:30:17 - 17-Dec-25 |
| Sell* | 5,000 | 70.50p | Ordinary |
16:29:33 - 17-Dec-25 |
| Unknown* | 46,062 | 71.00p | Ordinary |
16:29:05 - 17-Dec-25 |
| Sell* | 225 | 70.50p | Ordinary |
16:27:17 - 17-Dec-25 |
| Sell* | 60,000 | 70.50p | Ordinary |
16:27:05 - 17-Dec-25 |
| Sell* | 28,374 | 70.488p | Ordinary |
16:26:42 - 17-Dec-25 |
| Sell* | 500 | 70.4535p | Ordinary |
16:26:36 - 17-Dec-25 |
| Buy* | 1,114 | 71.25p | Ordinary |
16:25:29 - 17-Dec-25 |
Avacta Group (AVCT) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 17th Dec 2025 7:00 am | RNS | Faridoxorubicin Phase 1b SGC data |
| 8th Dec 2025 7:00 am | RNS | Preliminary Data in Faridoxorubicin Phase 1b Trial |
| 3rd Nov 2025 8:24 am | RNS | Completion of Placing and TVR |
| 27th Oct 2025 5:39 pm | RNS | Block Listing Six Monthly Return |
| 27th Oct 2025 7:00 am | RNS | Avacta presents preclinical data at AACR-NCI-EORTC |
| 23rd Oct 2025 5:00 pm | RNS-R | Notice of Investor Presentation |
| 20th Oct 2025 7:01 am | RNS | Equity fundraise of £16 million |
| 20th Oct 2025 7:00 am | RNS | Avacta Presents Phase 1a Data for Faridoxorubicin |
| 13th Oct 2025 7:00 am | RNS | Avacta to present data at EORTC-NCI-AACR |
| 30th Sep 2025 7:00 am | RNS | Interim Half Year Results 2025 |
